Details of the Drug

General Information of Drug (ID: DMI9VGL)

Drug Name
131I-labelled CLR 131
Indication
Disease Entry ICD 11 Status REF
Waldenstrom macroglobulinemia 2A85.4 Phase 2 [1]
Drug Type
Radiopharmaceutical therapy agent
Cross-matching ID
TTD ID
DH0M2P

References

1 Clinical pipeline report, company report or official report of Cellectar.